Genome Web Breaking News
- Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers
- Neuropsychiatric Disease Clues Drawn From Enhancer Expression Analysis
- OmicaBio, GenobankIo Partner on Tokenized Consent Protocol for Sequencing Study
- NIH Launches $42.5M Program to Establish Function of Every Human Gene
- Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes
Stat
- Alzheimer’s treatment slowed cognitive decline in closely watched clinical trial
- In new guidance, FDA says AI tools to warn of sepsis should be regulated as devices
- Google’s hospital play, Optum’s data shakeup, & the call for more telehealth oversight
- STAT+: Top FDA official acknowledges agency’s slow process for reviewing health app updates
- New study sees possible link between aluminum in childhood vaccines and risk of asthma, but caveats abound
NYT science news
- Photos Show NASA’s DART Spacecraft Crashing Into Asteroid
- A New Shot Guards Against H.I.V., but Access for Africans Is Uncertain
- How About Them Apples? Research Orchards Chart a Fruit’s Future.
- NASA Smashes Into an Asteroid, Completing a Mission to Save a Future Day
- Watch NASA’s DART Mission to Crash Into an Asteroid and Defend the Earth
Fierce Biotech
- Intuitive joins $14M funding for lung cancer AI developer Optellum
- Nykode hits early-stage goals for pan-variant COVID shot, but future plans murky
- Months after an executive exodus, Exicure tells 66% of staff to exit as it suspends all R&D work
- FDA hands Philips its 5th Class I recall of the year for faulty ventilators
- Genentech pays $70M to access Arsenal's armory of T-cell tools in quest for solid tumor CAR-T
Fierce Medical Devices
- Intuitive joins $14M funding for lung cancer AI developer Optellum
- FDA hands Philips its 5th Class I recall of the year for faulty ventilators
- MIT 'human radar' device tracks movement, gait speed of Parkinson's patients at home
- Smith+Nephew brings robotic assistant to knee replacement revision procedures
- Seer Medical scopes out FDA nod for at-home epilepsy monitoring system